Abstract
PD-9 Anti-HER2 therapy following ctDNA-identified ERBB2 amplification for patients with advanced gastric cancer: Exploration of real-world outcomes and resistance mechanisms
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
